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Background: Obesity is associated with adverse atherosclerotic cardiovascular events. While various metabolic abnormalities associated with 
obesity promote plaque formation, the morphological phenotype of these lesions have not been well characterized in obesity. High resolution 
vascular imaging with frequency domain optical coherence tomography (FD-OCT) enables the visualization of microstructures associated with plaque 
instability in vivo. We sought to characterize the presence of plaque microstructures in patients with and without obesity.
methods: FD-OCT imaging of 289 non-culprit plaques was performed in 275 patients with coronary artery disease undergoing percutaneous 
coronary intervention. Patients were stratified according to the presence or absence of obesity (body mass index >30 kg/m2). Plaques in obese 
(n=124) and non-obese (n=165) patients were compared with regard to clinical characteristics and FD-OCT-derived features of plaque vulnerability.
results: Obese patients were more likely to be younger (59 vs. 63 years, p=0.006), female (36 vs. 21%, p=0.03) and have a history of hypertension 
(66 vs. 43%, p<0.001). Higher levels of LDL-C (103 vs. 92 mg/dl, p=0.009), triglyceride (155 vs. 90 mg/dl, p<0.0001), fasting glucose (131 vs. 
118mg/dl, p=0.02) and a lower level of HDL-C (40 vs. 46 mg/dl, p=0.0002) were observed in obese patients. FD-OCT imaging demonstrated thinner 
fibrous caps (90.3±52.2 vs. 104.1±59.8μm, p=0.01) and a higher prevalence of thin-cap fibroatheroma (45 vs. 29%, p=0.003) in obese patients. 
The longitudinal extent of plaque rupture was greater in obese patients (3.9 vs.1.7mm, p=0.03). Following adjustment for differences in clinical 
characteristics, obese patients continued to demonstrate thinner fibrous caps (93.5 vs. 106.8μm, p=0.03). Achieving a LDL-C level <70 mg/dl was 
associated with thicker fibrous caps in both obese (108.2 vs. 84.6μm, p=0.03) and non-obese (120.6 vs. 98.8μm, p=0.04) patients.
conclusions: Obese patients harbor more vulnerable plaques in association with atherogenic risk factors. However, obese patients retain the 
ability to derive a beneficial impact from intensive LDL-C lowering therapy.
